We are monitoring the impact of COVID-19 on APAC Precision Medicine Software Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2021
ID: 11933
Share on
Share on

Asia-Pacific Precision Medicine Software Market Research Report – Segmented By Delivery Mode, Application, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: August, 2021
ID: 11933
Pages: 100

APAC Precision Medicine Software Market Size (2021 to 2026)

The size of the precision medicine software market in the APAC region is forecasted to be growing at a CAGR of 10.2% from 2021 to 2026.

The paradigm shift in treatment, the increasing pressure to reduce healthcare costs, scientific and technological advancements in genomics, and the increasing focus on providing complementary diagnostics and biomarkers for various therapeutic areas are some of the key factors that are expected to drive the precision medicine software market growth in this region.

The APAC precision medicine software market is expected to register substantial growth in the near future, driven by increased collaboration between research institutes and enterprises, increased licensing agreements, and business-to-business partnerships. Furthermore, the increased investment in precision medicine R&D. Additionally, increasing government funding for precision medicine initiatives and a growing cancer patient base are fueling the growth of the precision medicine software market.

Another major driver of the market includes developing a new generation of clinical minor sequencing, whole-genome technology, diagnostics, and accompanying augmentation. Due to genetic disease to ensure the rapid recovery of the patient and software specially developed for specific drugs used in the treatment of chronic diseases, it is expected that there will be a great future development of the market. With the growth of the precision medicine software market, software technologies increase in the near future, like big data analysis and gene therapy, to increase the acceptance of gene sequencing. Furthermore, the introduction of artificial intelligence and cloud-based solutions in precision medicine and the increase in genomic, metabolic, and proteomic data generated from research studies and clinical trials are expected to provide significant opportunities for the growth of market players in the upcoming years.

However, the lack of knowledge of precision medicine technology and the fragmentation of healthcare systems in developing countries in the APAC region are hampering the growth of this market to some extent.

Impact of COVID-19 on the APAC precision medicine software market:

With the health sector facing a crisis in the midst of the pandemic, he has been working on various solutions to tackle the pandemic. The healthcare industry is dedicated to precision medicine research to understand COVID-19 better and measure the impact caused by the virus to uncover potential therapies. Many governments have taken initiatives to speed up the use of precision coronavirus drugs. For example, researchers at Emory University are studying an antiviral compound that works like Remdesivir, which inhibits viral replication. This market has aided in the fight against the covid-19 virus.

This research report on the APAC precision medicine software market has been segmented and sub-segmented into the following categories:

By Delivery Mode:

  • Web & Cloud-Based
  • On-Premise

By Application:

  • Oncology
  • Pharmacogenomics
  • Rare Diseases
  • Other Applications

By End User:

  • Healthcare Providers
  • Research Centers and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the APAC region is expected to be the fastest-growing regional precision medicine software market for the global market during the forecast period. China is expected to be a world leader in precision medicine software. China, the world's second-largest economy, is expected to reach a projected market size of $ 547.8 million by 2028, with a CAGR of 13.9% over the review period 2021-2028. On the other hand, with well-developed healthcare and research infrastructure, Japan is expected to grow by 7.6% for the forecasted period.

The Chinese population and their government's penchant for data sharing are beneficial for AI (Artificial Intelligence) companies. China strengthened its emerging field of precision medicine after investing in WuXi NextCode. The investment has generated commercial interest on the continent in terms of precision medicine. In addition, the country targets heart disease and specific cancers such as liver and stomach cancers. These factors should allow the precision medicine software market to develop in China.

Other APAC regions are also expected to have lucrative growth rates in countries such as Japan, South Korea, Australia, Singapore, and India. With the government grappling with declining traditional exports to South Korea, biotechnology is seen as a potential new growth engine. In addition, state-of-the-art infrastructure, standardized electronic medical records (EMRs), and integration of EMRs and genomic information are established to improve the South Korean healthcare system. These factors are expected to facilitate healthy market growth in South Korea in the upcoming years.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the APAC precision medicine software market profiled in this report are SOPHiA GENETICS SA, Syapse, Inc., Foundation Medicine, Inc., 2bPrecise LLC, Fabric Genomics, Human Longevity, Inc., Translational Software, Inc., Gene42, Inc., IBM Watson Group, LifeOmic Health, LLC, Sunquest Information Systems Inc., Koninklijke Philips N.V., and Flatiron Health, Inc.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation
    1. Precision Medicine Software Market, By Delivery
      1. Web & Cloud Based
      2. On-Premise
      3. Market Size Estimations & Forecasts (2021-2026)
      4. Y-o-Y Growth Rate Analysis
      5. Market Attractiveness Index
    2. Precision Medicine Software Market, By Application
      1. Oncology
      2. Pharmacogenomics
      3. Rare Diseases
      4. Other Applications
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
    3. Precision Medicine Software Market, By End User
      1. Healthcare Providers
      2. Research Centers and Academic Institutes
      3. Pharmaceutical and Biotechnology Companies
      4. Other End Users
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
  7. Geographical Landscape
    1. Precision Medicine Software Market, by Region
    2. Asia Pacific                                             
      1. By Country
        1. China                  
        2. India
        3. Japan                  
        4. South Korea
        5. Southeast Asia
        6. Australia & NZ
        7. Rest of Asia- Pacific
  8. Key Player Analysis
    1. SOPHiA GENETICS SA
      1. Business Description
      2. Products/Service
      3. Financials                             
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. Syapse, Inc.
    3. Foundation Medicine, Inc.
    4. 2bPrecise LLC
    5. Fabric Genomics
    6. Human Longevity, Inc.
    7. Translational Software, Inc.
    8. Gene42, Inc.
    9. IBM Watson Group
    10. LifeOmic Health, LLC
    11. Sunquest Information Systems Inc.
    12. Koninklijke Philips N.V.
    13. Flatiron Health, Inc.
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of delivery mode, application and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  10. Asia Pacific Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia Pacific Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  14. Japan Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  15. Japan Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  16. Japan Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  17. China Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  18. China Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  19. China Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  20. India Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  21. India Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  22. India Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  23. Australia Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  24. Australia Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  25. Australia Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  26. South Korea Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  27. South Korea Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  28. South Korea Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample